Key highlights from Aurobindo Pharma Limited (AUROPHARMA) Q2 FY24 Earnings Concall Revenue Growth Revenue grew 25.8% year-on-year to INR7,219 crores, driven by
Aurobindo Pharma Limited Q2 FY24 Earnings Conference Call Insights
Categories
pharmaceuticals
Suven Pharmaceuticals Ltd Q2FY24; 11% rise in Profits
Suven Pharma is in the business of Contract development & manufacturing organisation (CDMO), catering to the needs of global Pharma Industry. Financial
Valiant Organics Ltd Q2FY24; 81% fall in Profits
Valiant Organics is engaged in the business of Manufacturing of chemicals for Agro Intermediate and Pharma. Financial Results: Valiant Organics Ltd reported
Sanofi India Ltd Q2FY24; 16% rise in Profits
Sanofi India is engaged in Business of Manufacture and sale of pharmaceutical products. Financial Results: Sanofi India Ltd reported Revenues for Q2FY24
Supriya Lifescience Ltd Q2FY24; 41% rise in Profits
Supriya Lifescience is engaged in the manufacturing of Active pharmaceutical ingredients (APIs). As of March 31, 2021, the company produces 38 APIs
Sequent Scientific Ltd Q2FY24; 2% rise in Revenue
Sequent Scientific is India's leading animal health company, with presence in 5+ continents across 100 countries. Sequent Scientific Limited provides a wide-ranging
Divi’s Laboratories Ltd Q2 FY24 Earnings Conference Call Insights
Key highlights from Divi's Laboratories Ltd (DIVISLAB) Q2 FY24 Earnings Concall Business Overview Anticipating growth opportunities in contrast media, sartans, soon-to-expire patented
Ajanta Pharma Ltd Q2FY24; 24% rise in Profits
Ajanta Pharma is primarily engaged in development, manufacturing and marketing of speciality pharmaceutical quality finished dosages. Financial Results: Ajanta Pharma Ltd reported
TTK Healthcare Ltd Q2FY24; 60% rise in Profits
TTK Healthcare Ltd is engaged in the business of Pharmaceuticals, Consumer Products, Medical Devices, Protective Devices and Foods. It is a part
Sun Pharmaceuticals Industries Ltd Q2FY24; 6% rise in Profits
Sun Pharmaceutical Industries Ltd is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulations
Unichem Laboratories Ltd Q2FY24; 26% rise in Revenue
Unichem Laboratories Ltd is involved in pharmaceuticals in Generics, APIs and Contract Manufacturing (CMO) areas. Financial Results: Unichem Laboratories Ltd reported Revenues
Dr Reddys Laboratories Ltd Q2FY24; 33% rise in Profits
Dr. Reddy's Laboratories Ltd is a leading India-based pharamceutical company which offers a portfolio of products and services, including Active Pharmaceutical Ingredients
Cipla Ltd Q2FY24; 45% rise in Profits
Cipla is engaged in the Business of Pharmaceuticals.(Source : 202003 Annual Report Page No:157) Financial Results: Cipla Ltd reported Revenues for Q2FY24
Strides Pharma Science Ltd Q2FY24; 11% rise in Revenue
Strides Pharma Science Ltd is in the business of development and manufacturing of pharmaceutical products. The company's pharmaceutical products are sold in
Cipla Limited Q2 FY24 Earnings Conference Call Insights
Key highlights from Cipla Limited (CIPLA) Q2 FY24 Earnings Concall Financial Performance Highest ever quarterly revenue of INR6,678 crores, up 15% YoY.
Laurus Labs Ltd Q2FY24; 79% fall in Profits
Founded in 2005, Laurus Labs is a research-driven pharmaceutical and biotechnology company having a global leadershipposition in select Active Pharmaceutical Ingredients (APIs)
Indoco Remedies Ltd Q2FY24; 30% fall in Profits
Indoco Remedies (Indoco) is a Mumbai-based pharmaceutical company that focuses on formulations with a presence in contract manufacturing and research. The Company
Torrent Pharmaceuticals Ltd Q2 FY24 Earnings Conference Call Insights
Key highlights from Torrent Pharmaceuticals Ltd (TORNTPHARM) Q2 FY24 Earnings Concall Revenue Growth Across Key Markets India business revenue grew 18% year-on-year;
Torrent Pharmaceuticals Ltd Q2FY24; 24% rise in Profits
Torrent Pharmaceuticals Ltd is one of the leading Indian Pharmaceutical Company engaged in research, development, manufacturing and marketing of generic pharmaceutical formulations.
Aarti Drugs Ltd Q2FY24; 5% fall in Profits
Established in the year 1984 and a part of $1000 million Aarti Group of Industries, Aarti Drugs Ltd. (ADL) is engaged into
Gufic BioSciences: Advancements & Strategic Developments in Pharmaceuticals
“We are also happy to announce that Gufic has secured DCGI approval for the manufacturing and marketing of Dalbavancin and we are